
 
 
 
 
 
 
 
 
   
 1. A composition comprising a LT-A/CT-B hybrid enterotoxin holotoxin recombinantly produced using plasmid pLT-A/CT-B assigned ATCC accession number PTA-6116, which holotoxin has immunologic adjuvant activity and is less toxic than native  E. coli  heat-labile enterotoxin holotoxin as measured in the patent mouse assay. 
 
     
 2. A composition comprising a LT-A(R192G)/CT-B hybrid enterotoxin holotoxin, which holotoxin has immunologic adjuvant activity and is less toxic than native  E. coli  heat-labile enterotoxin holotoxin as measured in the patent mouse assay. 
 
   
 
 
 
 
 
 
 
 
